Our team

Accelerating life science innovation requires a passionate team with deep industry expertise, diverse viewpoints, and creative approaches.

Kerensa Jimenez

Kerensa Jimenez

CEO, Paragon Health Capital

Kerensa Jimenez serves as chief executive officer at Paragon Health Capital, providing advisory services to Paragon Biosciences portfolio companies for all stages of financing and M&A needs. She works closely with Paragon and the executive management teams of its portfolio companies to raise growth capital, ranging from Series A to pre-IPO rounds of financing (both equity and debt).

Kerensa Jimenez brings more than 15 years of experience advising clients on M&A and financing transactions. Prior to joining Paragon Health Capital, she served as managing director of Octagon Capital Group, a top-tier merchant bank that has led numerous transactions for Paragon Biosciences portfolio companies over the past several years. Earlier in her career, Ms. Jimenez was a director at Farlie Turner, a middle market investment bank, where she provided M&A advisory services to private equity clients and business owners in the healthcare, consumer, energy, and business services sectors. She received a Bachelor of Science in economics from the University of Pennsylvania’s Wharton School.